TMF Physician First In East Texas To Implant Groundbreaking Heart Technology - CHRISTUS Trinity Mother Frances Health System

Skip to Content

Section Menu

News & Media

Published on January 12, 2016

TMF Physician First In East Texas To Implant Groundbreaking Heart Technology


TYLER, TX – Ramon Kumar, MD, treated a local patient at the Louis and Peaches Owen Heart Hospital at Trinity Mother Frances with a newly approved SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent from Boston Scientific making her the first patients in East to benefit from this highly anticipated new technology. The SYNERGY Stent was approved for use by the FDA on Oct. 5, 2015. Stents are tiny mesh tubes doctors use to prop open clogged arteries, allowing blood to flow freely to the heart.


“Bringing the most advanced medical technologies to our community directly supports our mission to provide outstanding patient care,” said Dr. Kumar. “Early adoption of the SYNERGY Stent, the first and only bioabsorbable polymer drug eluting stent in the U.S., reinforces our commitment to deliver advanced treatment to patients in East Texas and the surrounding communities.”


Manufactured by Boston Scientific, the SYNERGY Stent, with its bioabsorbable polymer, offers simultaneous drug and polymer absorption. Designed for faster healing, the SYNERGY Stent offers what you need when you need it; medicine, which inhibits coronary blockages from recurring, and freedom from permanent polymer exposure, which has been associated with complications such as vessel re-narrowing and blood clots.


“We are pleased to be working closely with Dr. Kumar and the Louis and Peaches Owen Heart Hospital at Trinity Mother Frances to ensure patients can access this innovative technology,” said Kevin Ballinger, President, Interventional Cardiology, Boston Scientific. “In development for over 10 years, the SYNERGY Stent reflects our commitment to bringing meaningful change to interventional cardiologists with the most complete portfolio of clinical solutions to best treat their patients,” said Ballinger. “We are excited to bring this transformative technology to U.S. facilities that provide best-in-class patient care.”


-- MORE --





The SYNERGY Stent is being studied in more than 15,000 patients worldwide, and has documented outstanding safety and efficacy of the Bioabsorbable Polymer Everoliumus Eluting Platinum Chromium Stent. For images and video showing the SYNERGY stents unique properties please click here.


Dr.Kumar is a Trinitry Clinic Cardiologist with special expertise in interventional and endovascular therapies. He was trained at Harvard Medical School/Beth Israel Deaconess as well as the Texas Heart Insitute. He, his wife and two children live in Tyler and he is taking new patients.


 About Trinity Mother Frances Hospitals and Clinics

Trinity Mother Frances Hospitals and Clinics include the Louis and Peaches Owen Heart Hospital, Mother Frances Hospital Tyler, Jacksonville and Winnsboro, Trinity Mother Frances Rehabilitation Hospital, affiliated with HEALTHSOUTH, Tyler ContinueCARE Hospital, a long-term acute care facility, and Trinity Clinic. Trinity Clinic is the area's preferred multi-specialty medical group, with more than 330 Physicians and Advanced Practice Providers representing 36 specialties in 31 locations serving East Texas.  For more information on services available through Trinity Mother Frances, visit


About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit and connect on Twitter and Facebook.



Reviewed by Will Knous on January 12, 2016

Media Contact

Will Knous
Media Relations
(903) 530-5065